Abemaciclib for treating patients with HR+/HER2- metastatic breast cancer: a real-world study in France, Italy and Spain.
Blancas I, Grosjean J, Pedersini R, Buzzoni C, Sleilaty G, Molero A, Tamma A, Chouaki N, Atienza M, Emde A, Siddi S, Sanchez Bayona R, Del Mastro L, Fakhouri W.
Blancas I, et al. Among authors: tamma a.
Future Oncol. 2024;20(31):2371-2384. doi: 10.1080/14796694.2024.2368455. Epub 2024 Aug 8.
Future Oncol. 2024.
PMID: 39115881
Free PMC article.